(Q37695142)
Statements
In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7 (English)
Fanny Astruc-Diaz
Steven W McDaniel
Jijun J Xu
David L Brown
Mohamed Naguib
Philippe Diaz
28 November 2012
1 reference